Practice guideline update summary: Mild cognitive impairment
By Ronald C. Petersen, Oscar Lopez, M. Armstrong, Thomas S. D. Getchius, M. Ganguli, D. Gloss, G. Gronseth, D. Marson, T. Pringsheim, G. Day and 3 more. Neurology, 2018
1,793 citations recorded by the source corpus.
Subfields: Neurology, Psychiatry and Mental health, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/20db6dbc8d5c3eb933ed09b92e1a39dfb889a714
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Psychiatry and Mental health
Citations in the corpus
- The cholinergic system in the pathophysiology and treatment of Alzheimer's disease. (2018, background): “A recent practice guideline update could find no Level A evidence that cholinesterase inhibitors offer symptomatic improvement at the MCI stage (Petersen et al., 2018).”